TAKEDA PHARMACEUTICALS INTERNATIONAL AG -  

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:800-900
2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000

Ranking timeline:

Project Participation Performance(2019-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 20
As coordinator: 0
As participant: 20
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 3.260.000 0 1
2021 0 54.895.657 0 5
2020 0 96.335.902 0 5
2019 0 146.802.130 0 9

Networking:

Partners:

Institution:Projects [No]:
PFIZER LIMITED14
JANSSEN PHARMACEUTICA NV13
SANOFIAVENTIS12
NOVARTIS PHARMA11
BAYER9
TAKEDA DEVELOPMENT CENTRE EUROPE9
F HOFFMANNLA ROCHE7
ASTRAZENECA6
KATHOLIEKE UNIVERSITEIT LEUVEN6
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD6
ABBVIE INC5
ACADEMISCH ZIEKENHUIS GRONINGEN5
ELI LILLY AND COMPANY LIMITED5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE5
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN5
NOVO NORDISK5
STICHTING VUMC5
UCB BIOPHARMA5
UNIVERSITY COLLEGE LONDON5
ASTELLAS PHARMA EUROPE BV4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V4
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE4
INSTITUT DE RECHERCHES SERVIER4
KAROLINSKA INSTITUTE4
LEIDS UNIVERSITAIR MEDISCH CENTRUM4
STICHTING LYGATURE4
TEVA PHARMACEUTICAL INDUSTRIES LIMITED4
UNIVERSITY OF CAMBRIDGE4
ALZHEIMER EUROPE3
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG3
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS3
COMMISSARIAT A L'ENERGIE ATOMIQUE3
ETHNIKO KENTRO EREVNAS KAI TECHNOLOGIKIS ANAPTYXIS3
KING'S COLLEGE LONDON3
SERVICIO MADRILENO DE SALUD3
THE UNIVERSITY OF MANCHESTER3
UNIVERSITA VITASALUTE SAN RAFFAELE3
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
UNIVERSITEIT UTRECHT3
UNIVERSITY COLLEGE DUBLIN3
UNIVERSITY OF DUNDEE3
UNIVERSITY OF OSLO3
ACADEMIC MEDICAL CENTRE AMSTERDAM2
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN2
BIOBANKS AND BIOMOLECULAR RESOURCES RESEARCH INFRASTRUCTURE CONSORTIUM2
BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL2
CENTRE DE REGULACIO GENOMICA2
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL2
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER2
DREEM2
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE2
EUROPEAN CANCER PATIENT COALITION2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GOETEBORGS UNIVERSITET2
HELMHOLTZZENTRUM FUR INFEKTIONSFORSCHUNG2
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES2
IXSCIENT LIMITED2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
JULIUS CLINICAL RESEARCH BV2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LUND UNIVERSITY2
LYSOGENE2
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV2
MCROBERTS BV2
MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY2
MEDIZINISCHE HOCHSCHULE HANNOVER2
MEDIZINISCHE UNIVERSITAET WIEN2
MEDTRONIC INTERNATIONAL TRADING SARL2
OSPEDALE PEDIATRICO BAMBINO GESU2
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG2
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON2
REGION STOCKHOLM2
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU2
STICHTING MLC FOUNDATION2
STICHTING UNITED PARENT PROJECTS MUSCULAR DYSTROPHY2
STIFTUNG TIERAERZTLICHE HOCHSCHULE HANNOVER2
SYDDANSK UNIVERSITET2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
THE HYVE BV2
THE UNIVERSITY OF SHEFFIELD2
TTOPSTART BV2
UNIVERSITA DEGLI STUDI DI FERRARA2
UNIVERSITA DEGLI STUDI DI SIENA2
UNIVERSITATSKLINIKUM ERLANGEN2
UNIVERSITE DE GENEVE2
UNIVERSITY OF BERGEN2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF GLASGOW2
UNIVERSITY OF LEICESTER2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIWERSYTET JAGIELLONSKI2
UPPSALA UNIVERSITET2
VIB VZW2
VRIJE UNIVERSITEIT BRUSSEL2
2CONTROL APS1

Constancy:

Total number of partners: 616
Partner loyalty:
Frequent Partner: (> 2 projects): 220
Rare Partner: 396
Frequent / Rare Partner Ratio: 0.56

Project overview:

Start dateProjectacronymrolefundingpartners
2022-01-01FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem FACILITATEparticipant3.260.00029
2021-11-01European platform for neurodegenerative disorders EPNDparticipant9.680.00029
2021-10-01Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies SCREEN4CAREparticipant11.938.56937
2021-09-01BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe BEAMERparticipant5.948.90331
2021-09-01Innovations to accelerate vaccine development and manufacture Inno4Vacparticipant18.600.00041
2021-01-01Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy T2EVOLVEparticipant8.728.18529
2020-11-01Accelerating Research & Development for Advanced Therapies ARDATparticipant11.773.00034
2020-10-01H2O Health Outcomes Observatory H2Oparticipant10.476.68725
2020-07-01COVID-19 infections - Remote Early Detection COVID-REDparticipant9.592.02910
2020-05-01EUbOPEN: Enabling and Unlocking biology in the OPEN EUbOPENparticipant27.935.00023
2020-04-01Corona Accelerated R&D in Europe CAREparticipant36.559.18642
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2019-10-01Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies Immune-Imageparticipant15.000.00023
2019-09-01Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials Trials@Homeparticipant19.036.99833
2019-09-01Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions 3TRparticipant40.273.19270
2019-04-01Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement MOBILISE-Dparticipant25.395.89735
2019-04-01Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation ConcePTIONparticipant15.299.99153
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETparticipant1.199.12510
2019-03-01EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells EBiSC2participant4.599.64818
2019-01-01Remote Assessment of Disease and Relapse – Alzheimer’s Disease RADAR-ADparticipant4.999.75717